This course features 3 sessions from the 2011 PH Professional Network Symposium that focus on issues of special interest to pharmacists. These topics include transition of medications between inpatient and outpatient care, transitioning patients between medications and medication safety. This course is offered for a maximum of 3.0 hours of pharmacy CEUs.
Diahann K. Wilcox, APRN, University of Connecticut Health Center
Traci Housten, RN, MS, Johns Hopkins Pulmonary Hypertension Program
Steve Walker, MS, CRNP, The Children's Hospital of Philadelphia
Patricia Louzon, Pharm D, BCPS, Florida Hospital Orlando
Charles D. Burger, MD, FCCP, Mayo Clinic Florida
Glenna L. Traiger, RN, MSN, University of California Los Angeles
Martha S. Kingman, FNP-C, DNP, UT Southwestern Medical Center- Dallas
Jennifer Priziola, Pharm D, BCPS, Beaumont Hospital
This activity is a self-study activity. Upon entering the activity, participants should read the text, examine any images and/or multimedia features, and review the content presented within all of the links provided. Once the course has been reviewed in its entirety, participants will be asked to complete a post-test and evaluation online. Participants must receive a test score of 100% in order to proceed to the course evaluation; the post-test can be repeated until all questions are answered correctly. All evaluation questions must be completed in order to receive a certificate of credit. If needed, participants may save their answers and complete the course at a later date. Saved courses can be found by using the "My Courses" link at the top of the page, and then click on "My Classes".
This activity is co-sponsored by ProCE, Inc. and the Pulmonary Hypertension Association. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-999-11-090-H01-P has been assigned to this knowledge-based home-study CE activity (initial release date 12-15-11). This activity is approved for 3.0 contact hours (0.30 CEUs) in states that recognize ACPE providers. The activity is provided at no cost to participants. Statements of credit will be issued online upon completion of the activity evaluation and the post-test with a score of 100%. No partial credit will be given.
As a provider accredited by ACPE, it is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all educational activities. A potential for bias may exist if a continuing education faculty member is affiliated with or has a financial interest in any organization(s) that may have a direct interest in the subject matter of the presentation. Situations involving potential bias are not inherently problematic or unethical, but the prospective audience must be made aware of the affiliation or financial interest. It is intended that any potential bias be identified openly so that the audience is provided full disclosure of the facts and may form their own judgments about the continuing education activity content.
Jennifer Priziola, PharmD, BCPS, indicates no relevant financial and or commercial relationships to disclose.
Martha S. Kingman, FNP-C, DNP, indicates she has served as a speaker for Actelion, Gilead and United Therapeutics.
Steve Walker, MS, CRNP indicates that the session may include discussion of FDA off label, investigational or experimental drug use.
Traci Housten, RN, MS, indicates that the session may include discussion of FDA off label, investigational or experimental drug use.
Diahann K. Wilcox, APRN, indicates that the session may include discussion of FDA off label, investigational or experimental drug use.
Glenna L. Traiger, RN, MSN, indicates no relevant financial and or commercial relationships to disclose.
Charles D. Burger, MD, FCCP indicates no relevant financial or commercial relationships to disclose
Patricia Louzon, Pharm D, BCPS, indicates no relevant financial and or commercial relationships to disclose.
Please note: The opinions expressed in this activity should not be construed as those of the CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
No portion of this activity may be reproduced without the expressed written consent of PHA.
©2012 Pulmonary Hypertension Association, 801 Roeder Road, Suite 1000, Silver Spring, MD 21910.
Web Browser: for optimal viewing, please use Mozilla Firefox or Safari.